# Prophylaxis of Neuropathic Pain by mémantine

> **NCT01536314** · PHASE3 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 43 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Memantine EBIXA®
- **DRUG:** Placebo : lactose

## Key facts

- **NCT ID:** NCT01536314
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536314, "Prophylaxis of Neuropathic Pain by mémantine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01536314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*